Prodrugs of gestodene for matrix-type transdermal drug delivery systems

Pharmaceutical Research

Volumn 15, Issue 9, 1998, Pages 1419-1424

  Lipp, Ralph ^a   Laurent, Henry ^a   Günther, Clemens ^a   Riedl, Jutta ^a   Esperling, Peter ^a   Täuber, Ulrich ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Drug design; Gestodene caproate; Prodrug; Progestin; Transdermal drug delivery system

Indexed keywords

GESTAGEN; GESTODENE; PRODRUG;

ANIMAL TISSUE; ARTICLE; DRUG ACETYLATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG HYDROLYSIS; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; ENVIRONMENTAL TEMPERATURE; FLOW RATE; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SKIN ABSORPTION; TRANSDERMAL DRUG ADMINISTRATION;

ACYLATION; ADMINISTRATION, CUTANEOUS; ANIMALS; BIOLOGICAL TRANSPORT; CONTRACEPTIVES, ORAL, SYNTHETIC; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG STORAGE; GESTONORONE CAPROATE; MALE; MICE; MICE, NUDE; NORPREGNENES; PRODRUGS; PROGESTERONE CONGENERS; SOLUBILITY; TEMPERATURE;

EID: 0031754210     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011957822961     Document Type: Article

References (25)

1. P. Mauvais-Jarvis, C. F. H. Vickers, and S. Wepierre. Percutaneous absorption of steroids, Academic Press, London, 1980.
2. H-D. Taubert and H. Kuhl. Das Klimakterium, Georg Thieme Verlag, Stuttgart, 1987.
3. D. R. Friend. Transdermal Delivery of Contraceptives. Crit. Rev. in Ther. Drug Carrier Syst. 7:149-186 (1990).
4. M. Elstein. Gestodene, The Parthenon Publishing Group. Carnforth, UK, 1987.
5. C. Günther. In vitro-und in vivo-Untersuchungen zur perkutanen Resorption von Estrogenen und Gestagenen als Grundlage für die Entwicklung eines transdermalen therapeutischen Systems. Ph. D. Thesis. Freie Universität Berlin, Berlin (1990).
6. C. Günther, U. Tauber, K. Schmidt-Gollwitzer, J. Riedl, and J. W. Tack. Transdermal steroid hormone compositions. DE 3,836,862, 1990, Schering AG: Chem. Abstr. 113:218251f (1990).
7. Y. W. Chien. Systemic delivery of pharmacologically active molecules across the skin. In R. L. Juliano (ed.) Targeted Drug Delivery, Springer-Verlag, Berlin, Heidelberg, New York, 1991, pp. 181-230.
8. J. Yu, T. Chien, and Y. W. Chien. Transdermal dual-controlled delivery of testosterone and estradiol: (I) impact of system design. Drug. Dev. Ind. Pharmacy 17:1883-1904 (1991).
9. R. Lipp and A. Müller-Fahrnow. X-ray structure determinations of crystals grown in transdermal delivery systems containing estradiol or gestodene. Pharm. Res. 11:S-213 (1994).
10. R. Lipp, J. Riedl, and J. W. Tack. Transdermal therapeutic systems containing crystallization inhibitors. WO 93/08795, 1993, Schering AG, Chem. Abstr. 119:P15357w (1993).
11. R. Lipp. Selection and use of crystallization inhibitors for steroid loaded transdermal delivery systems. Eur. J. Pharm. Biopharm. 40(suppl):85 (1994).
12. 15-17α-Äthinyl-steroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate, DE 2,546,062, 1977; Schering AG, Chem. Abstr. 87:168265 (1977).
13. H. Hofmeister, K. Annen, H. Laurent, K. Petzoldt, and R. Wiechert. Synthesen von Gesinden. Arzneim.-Forsch. (Drug Res.) 36:781-783 (1986).
14. R. Lipp, H. Laurent, C. Günther, J. Riedl, P. Esperling, and U. Täuber. Transdermal formulations containing gestodene esters. DE 4,329,242, 1995, Schering AG; Chem. Abstr. 122:248319 (1995).
15. B. W. Barry. Dermatological formulations. Marcel Dekker, New York, 1983.
16. K. B. Sloan (ed.). Prodrugs, topical and ocular drug delivery. Marcel Dekker, New York, 1992 (J. Swarbrick, Ed., Drugs and the pharmaceutical sciences: Vol. 53).
17. K. H. Valia, K. Tojo, and Y. W. Chien. Long-term permeation kinetics of estradiol: (III) kinetic analysis of the simultaneous skin permeation and bioconversion of estradiol esters. Drug Dev. Ind. Pharmacy 11:1133-1173 (1985).
18. K. Junkmann and H. Witzel. Chemie und Pharmakologie von Steroidhormon-Estern. Z. Vitam. Horm. Fermentforsch. 9:97-143 (1958).
19. D. Gould, L. Finckenor, E. B. Hershberg, J. Cassidy, and P. L. Perlman. Long-acting testosterone esters. Some considerations on their biological utilization. J. Am. Chem. Soc. 79:4472-4475 (1957).
20. R. J. Scheuplein and K. L. Bronaugh. In. L. A. Goldsmith (ed.) Biochemistry and Physiology of the Skin. Oxford University Press, New York, 1983, pp. 1255-1295.
21. O. Brandt and C. Günther. In vitro and in vivo metabolism of testosterone in human and hairless vs. nude mouse skin. Exp. Toxic. Pathol. 48:334-335 (1996).
22. S. Ahmed, T. Imai, and M. Otagiri. Evaluation of stereoselective transdermal transport and concurrent hydrolisis of several ester prodrugs of propranolol: mechanism of stereoselective permeation. Pharmaceut. Res. 13:1524-1529 (1996).
23. R. C. O'Neil and J. E. Carless. Influence of side chain on the hydrolysis of hydrocortisone esters. J. Pharm. Pharmacol. 82:10 (1980).
24. E. Eckle, G.-A. Hover, H. Hofmeister, H. Laurent, D. Schomburg, and R. Wiechert. Die Kristall- und Molekülstruktur von Gestoden. Liebigs Ann. Chem. 1988:199-202.
25. C log P software, Schering AG, 1992.